Susceptibility profile of clinical and environmental isolates ofCryptococcus neoformansandCryptococcus gattiiin Uberaba, Minas Gerais, Brazil

Epidemiologic cutoff values for triazole drugs in Cryptococcus gattii: correlation of molecular type and in vitro susceptibility

(2012) Shawn R. Lockhart et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Correlation of Susceptibility of Cryptococcus neoformans to Amphotericin B with Clinical Outcome

(2011) R. A. Larsen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans, and Aspergillus fumigatus: application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Antimicrobial Surveillance Program (2009)

(2010) Michael A. Pfaller et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Molecular characterization and evaluation of virulence factors of Cryptococcus laurentii and Cryptococcus neoformans strains isolated from external hospital areas

(2010) Leonardo Andrade-Silva et al.   Fungal Biology

The distribution of species and susceptibility of amphotericin B and fluconazole of yeast pathogens isolated from sterile sites in Taiwan

(2010) Y. L. Yang et al.   MEDICAL MYCOLOGY

Genotype and mating type distribution within clinicalCryptococcus neoformansandCryptococcus gattiiisolates from patients with cryptococcal meningitis in Uberaba, Minas Gerais, Brazil

(2010) Delio José Mora et al.   MEDICAL MYCOLOGY

Antifungal susceptibility, serotyping, and genotyping of clinicalCryptococcus neoformansisolates collected during 18 years in a single institution in Madrid, Spain

(2010) Jesús Guinea et al.   MEDICAL MYCOLOGY

Genotyping of Cryptococcus neoformans isolated from captive birds in Uberaba, Minas Gerais, Brazil

(2010) Kennio Ferreira-Paim et al.   MYCOSES

Microbiological characteristics of clinical isolates of Cryptococcus neoformans in Taiwan: serotypes, mating types, molecular types, virulence factors, and antifungal susceptibility

(2009) S-J. Liaw et al.   CLINICAL MICROBIOLOGY AND INFECTION

Correlation of Genotype and In Vitro Susceptibilities of Cryptococcus gattii Strains from the Pacific Northwest of the United States

(2009) N. Iqbal et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Urban Pigeons (Columba livia) as a Potential Source of Pathogenic Yeasts: A Focus on Antifungal Susceptibility of Cryptococcus Strains in Northeast Brazil

(2009) Ana K. F. Costa et al.   MYCOPATHOLOGIA

Molecular typing and antifungal susceptibility of clinical and environmental Cryptococcus neoformans species complex isolates in Goiania, Brazil

(2009) L. K. H. Souza et al.   MYCOSES

Fluconazole and amphotericin B susceptibility testing of Cryptococcus neoformans: Results of minimal inhibitory concentrations against 265 isolates from HIV-positive patients before and after two or more months of antifungal therapy

(2009) Alicia Irene Arechavala et al.   REVISTA IBEROAMERICANA DE MICOLOGIA

In vitro susceptibility of Cryptococcus gattii clinical isolates

(2008) A. Gomez-Lopez et al.   CLINICAL MICROBIOLOGY AND INFECTION

Regional pattern of the molecular types of Cryptococcus neoformans and Cryptococcus gattii in Brazil

(2008) Luciana Trilles et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

Suscetibilidade a antifúngicos de variedades de Cryptococcus neoformans isoladas de pacientes em hospital universitário

(2008) Paulo Roberto da Silva et al.   Revista da Sociedade Brasileira de Medicina Tropical